Age-related macular degeneration Meso-zeaxanthin Ocular Supplementation trial (AMOST)
Completed
- Conditions
- Age-related macular degenerationEye DiseasesOther retinal disorders
- Registration Number
- ISRCTN81595685
- Lead Sponsor
- Howard Foundations Holdings Limited (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1. Male or female, aged 50 years and above
2. Early stage AMD in at least one eye
3. No additional ocular pathology to AMD
Exclusion Criteria
1. Cigarette smokers
2. Currently taking dietary supplements and/or had been taking dietary supplements over the previous three months prior to their baseline study visit
3. Diabetics (HbA1c above 6.5%)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method